Photocontact allergic and phototoxic studies of chlorproethazine

Photodermatology Photoimmunology and Photomedicine

Volumn 24, Issue 1, 2008, Pages 11-15

  Kerr, Alastair ^a   Woods, Julie ^a   Ferguson, James ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Chlorproethazine; Neutral red uptake; Photocontact allergy; Photopatch test; Phototoxicity

Indexed keywords

CHLORPROETHAZINE; MUSCLE RELAXANT AGENT; PHENOTHIAZINE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IN VITRO STUDY; INCUBATION TIME; KERATINOCYTE; MALE; NORMAL HUMAN; OUTCOME ASSESSMENT; PHOTODERMATOSIS; PHOTOPATCH TEST; PHOTOTOXICITY; PRIORITY JOURNAL; RADIATION EXPOSURE; TOXICITY TESTING; ULTRAVIOLET A RADIATION; ULTRAVIOLET RADIATION;

CELLS, CULTURED; CHLORPROMAZINE; DERMATITIS, PHOTOTOXIC; FEMALE; HUMANS; INHIBITORY CONCENTRATION 50; KERATINOCYTES; MALE; NEUROMUSCULAR AGENTS; PATCH TESTS; SKIN; ULTRAVIOLET RAYS;

EID: 38349010522     PISSN: 09054383     EISSN: 16000781     Source Type: Journal    
DOI: 10.1111/j.1600-0781.2008.00324.x     Document Type: Article

References (11)

1. Agence francaise de securite sanitaire des produits de sante (afssaps) - Press release, February 19, 2007. http://afssaps.sante.fr/htm/10/ filocoprs/070206.htm
2. Neumann NJ, Holzle E, Plewig G, et al. Photopatch testing: The 12-year experience of the German, Austrian and Swiss photopatch test group. J Am Acad Dermatol 2000; 42: 183-192.
3. DeLeo VA, Suarez SM, Maso MJ. Photoallergic contact dermatitis. Results of photopatch testing in New York, 1985-1990. Arch Dermatol 1992; 128: 1513-1518.
4. Barbaud A, Collet E, Martin S, et al. Contact sensitization to chlorproethazine can induce persistent light reaction and cross-photoreactions to other phenothiazines. Contact Dermatitis 2001; 44: 373-374.
5. Loesche C, Dejobert Y, Thomas P. Immediate wheal after topical administration of chlorproethazine. Contact Dermatitis 1992; 26: 278.
6. Marguery MC. Contact allergy to chlorproethazine with photoaggravation. DermoFocus 2000; 7: 17-19.
7. Spielmann H, Muller L, Averbeck D, et al. The second ECVAM workshop on phototoxicity testing -the report and recommendations of ECVAM Workshop 421, 2. ATLA -Alternatives LabAnim 2000; 28: 777-814.
8. Traynor NJ, Beattie PE, Ibbotson SH, Moseley H, Ferguson J, Woods JA. Photogenotoxicity of hypericin in HaCaT keratinocytes: Implications for St John's wort supplements and high dose UVA-1 therapy. Toxicol Lett 2005; 158: 220-224.
9. Traynor NJ, Barrat MD, Lovell WW, Ferguson J, Gibbs NK. Comparison of an in-vitro cellular phototoxicity model against controlled clinical trials of fluoroquinolone skin phototoxicity. Toxicol in Vitro 2000; 14: 275-283.
10. Bruynzeel DP, Ferguson J, Andersen K, et al. European taskforce for photopatch testing. Photopatch testing: A concensus methodology for Europe (Review). J Eur Acad of Dermatol and Venereol 2004; 18: 679-682.
11. The European Agency for the Evaluation of Medicinal Products. Committee for Proprietary Medicinal Products (CPMP) -Note for guidance on Photosafety testing. London, 2002. http://www.emea.europa.eu/pdfs/human/ swp/039801en.pdf